Serum Insulin-like Factor 3, Testosterone and Luteinizing Hormone in Experimental and Therapeutic Testicular Suppression.

Jakob AlbrethsenPeter Busch ØstergrenPernille Badsberg NorupJens SønksenMikkel FodeCaroline KistorpNikolai B NordsborgSara Amalie SolheimJakob MørkebergKatharina M MainAnders Juul

Published in: The Journal of clinical endocrinology and metabolism (2023)

INSL3 resembles testosterone as a sensitive marker of testicular suppression and reflects Leydig cell function, also during exposure to exogenous testosterone. Serum INSL3 measurements may complement testosterone as a Leydig cell marker in male reproductive disorders, during therapeutic testicular suppression as well as in surveillance of illicit use of androgens.

Keyphrases

replacement therapy
germ cell
smoking cessation
stem cells
adipose tissue
cell therapy
skeletal muscle